Comprehensive assessment of genetic variation of catechol-O- methyltransferase and breast cancer risk

Mia M. Gaudet, Stephen Chanock, Jolanta Lissowska, Sonja I. Berndt, Beata Peplonska, Louise A. Brinton, Robert Welch, Meredith Yeager, Alicja Bardin-Mikolajczak, Montserrat Garcia-Closas

Research output: Contribution to journalArticlepeer-review

Abstract

Because catechol-O-methyltransferase (COMT) catalyzes the addition of methyl groups to stabilize catechol estrogens that may induce DNA damage, genetic variants could influence breast cancer risk. To comprehensively characterize genetic variation in this gene, we selected haplotype-tagging single nucleotide polymorphisms (htSNP) in COMT. A total of 11 htSNPs (including COMT Val158Met) were selected based on the resequencing and dense genotyping approach of the Breast and Prostate Cancer Cohort Consortium. htSNPs were genotyped in a population-based, case-control study in Poland (1,995 cases and 2,296 controls). Individual SNPs were not significantly associated with risk. Haplotypes were estimated using the expectation-maximization algorithm. Overall differences in the haplotype distribution between cases and controls were assessed using a global score test. The TGAG haplotype (frequent in 4.3% of controls), in a linkage disequilibrium (LD) block that included the 3′ untranslated region (UTR) of COMT, was associated with breast cancer risk (odds ratio, 1.29; 95% confidence interval, 1.06-1.58) compared with the most common haplotype TGAA; however, the global test for haplotype associations was not significant (P = 0.09). Haplotypes in another LD block, which included COMT Val158Met, were not associated with breast cancer risk (global P = 0.76). Haplotype-breast cancer risk associations were not significantly modified by hormonally related risk factors, family history of breast cancer, or tumor characteristics. In summary, our data does not support a substantial overall association between COMT haplotypes and breast cancer. The suggestion of increased risk associated with a haplotype in the 3′ UTR of COMT needs to be confirmed in independent study populations.

Original languageEnglish (US)
Pages (from-to)9781-9785
Number of pages5
JournalCancer Research
Volume66
Issue number19
DOIs
StatePublished - Oct 1 2006

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Comprehensive assessment of genetic variation of catechol-O- methyltransferase and breast cancer risk'. Together they form a unique fingerprint.

Cite this